Global Marine Drug Market
Global Marine Drug Market

Marine Drug Comprehensive Study by Distribution Channel (Online {Company Website, E-Commerce Website}, Offline {Pharma Stores, Local Medical Stores}), End Use (Hospitals, Clinics, Diagnostic Centers), Sources (Sponges, Soft Corals, Sea Fans, Sea Hares, Nudibranchs, Bryozoans, Tunicates) Players and Region - Global Market Outlook to 2027

Marine Drug Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Feb 2022 Edition 220 Pages 219 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
The advent of new diseases as a result of the constantly changing environment and the growing global population has put a strain on the available medicine supply. Drug companies are always working to develop effective and safe pharmaceuticals to meet the growing demands of the world's population. The growing use of marine-derived medications in the treatment of malignancies that cause infections is propelling the global market for marine-derived drugs. They're also being used in the treatment of tuberculosis, malaria, osteoporosis, viral illnesses, and HIV, which is unthinkable. Furthermore, the introduction of new screening innovations and the development of marine condition exercises are contributing considerably to the global growth of the market for marine-derived pharmaceuticals.
This growth is primarily driven by Growing Diseases Like Cancer, Malaria and Rapidly Expansion Of Pharmaceutical Industry.

Globally, a noticeable market trend is evident Growing Investments In Research Activities Related To Marine Drugs . Major Players, such as PharmaMar (Spain), Pfizer (United States), GSK (United Kingdom), Eisai Co., Ltd. (United States), Johnson and Johnson (United States), Seattle Genetics Inc. (United States), Eisai Co (Japan), Tekada (Japan) and TerSera Therapeutics (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Growing Diseases Like Cancer, Malaria
  • Rapidly Expansion Of Pharmaceutical Industry

Market Trend
  • Growing Investments In Research Activities Related To Marine Drugs
  • High Investment In Pharmaceuticals Industries

Restraints
  • High Cost Associated With Development Of Drug

Opportunities
Presence Of A Well-Developed Healthcare Infrastructure and Rising Awareness About The Benefits Of These Drugs
Challenges
Side-Effects Of Marine Drug

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Marine Drug Study Sheds Light on
— The Marine Drug Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Marine Drug industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Marine Drug industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Marine Drug Market?
The Marine Drug market is expected to see a CAGR of % during projected year 2021 to 2027.

2. Who are the top performing companies in Marine Drug Market?
Top performing companies in the Global Marine Drug market are PharmaMar (Spain), Pfizer (United States), GSK (United Kingdom), Eisai Co., Ltd. (United States), Johnson and Johnson (United States), Seattle Genetics Inc. (United States), Eisai Co (Japan), Tekada (Japan) and TerSera Therapeutics (United States), to name a few.

3. Which region dominated the worldwide market for Marine Drug in 2021?
is dominating the Marine Drug Market.
Report Objectives / Segmentation Covered
By Distribution Channel
  • Online {Company Website, E-Commerce Website}
  • Offline {Pharma Stores, Local Medical Stores}

By End Use
  • Hospitals
  • Clinics
  • Diagnostic Centers

By Sources
  • Sponges
  • Soft Corals
  • Sea Fans
  • Sea Hares
  • Nudibranchs
  • Bryozoans
  • Tunicates

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Diseases Like Cancer, Malaria
      • 3.2.2. Rapidly Expansion Of Pharmaceutical Industry
    • 3.3. Market Challenges
      • 3.3.1. Side-Effects Of Marine Drug
    • 3.4. Market Trends
      • 3.4.1. Growing Investments In Research Activities Related To Marine Drugs
      • 3.4.2. High Investment In Pharmaceuticals Industries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Marine Drug, by Distribution Channel, End Use, Sources and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Marine Drug (Value)
      • 5.2.1. Global Marine Drug by: Distribution Channel (Value)
        • 5.2.1.1. Online {Company Website, E-Commerce Website}
        • 5.2.1.2. Offline {Pharma Stores, Local Medical Stores}
      • 5.2.2. Global Marine Drug by: End Use (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Diagnostic Centers
      • 5.2.3. Global Marine Drug by: Sources (Value)
        • 5.2.3.1. Sponges
        • 5.2.3.2. Soft Corals
        • 5.2.3.3. Sea Fans
        • 5.2.3.4. Sea Hares
        • 5.2.3.5. Nudibranchs
        • 5.2.3.6. Bryozoans
        • 5.2.3.7. Tunicates
      • 5.2.4. Global Marine Drug Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Marine Drug (Price)
  • 6. Marine Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. PharmaMar (Spain)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GSK (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eisai Co., Ltd. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson and Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Seattle Genetics Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Eisai Co (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Tekada (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. TerSera Therapeutics (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Marine Drug Sale, by Distribution Channel, End Use, Sources and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Marine Drug (Value)
      • 7.2.1. Global Marine Drug by: Distribution Channel (Value)
        • 7.2.1.1. Online {Company Website, E-Commerce Website}
        • 7.2.1.2. Offline {Pharma Stores, Local Medical Stores}
      • 7.2.2. Global Marine Drug by: End Use (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Diagnostic Centers
      • 7.2.3. Global Marine Drug by: Sources (Value)
        • 7.2.3.1. Sponges
        • 7.2.3.2. Soft Corals
        • 7.2.3.3. Sea Fans
        • 7.2.3.4. Sea Hares
        • 7.2.3.5. Nudibranchs
        • 7.2.3.6. Bryozoans
        • 7.2.3.7. Tunicates
      • 7.2.4. Global Marine Drug Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Marine Drug (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Marine Drug: by Distribution Channel(USD Million)
  • Table 2. Marine Drug Online {Company Website, E-Commerce Website} , by Region USD Million (2016-2021)
  • Table 3. Marine Drug Offline {Pharma Stores, Local Medical Stores} , by Region USD Million (2016-2021)
  • Table 4. Marine Drug: by End Use(USD Million)
  • Table 5. Marine Drug Hospitals , by Region USD Million (2016-2021)
  • Table 6. Marine Drug Clinics , by Region USD Million (2016-2021)
  • Table 7. Marine Drug Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 8. Marine Drug: by Sources(USD Million)
  • Table 9. Marine Drug Sponges , by Region USD Million (2016-2021)
  • Table 10. Marine Drug Soft Corals , by Region USD Million (2016-2021)
  • Table 11. Marine Drug Sea Fans , by Region USD Million (2016-2021)
  • Table 12. Marine Drug Sea Hares , by Region USD Million (2016-2021)
  • Table 13. Marine Drug Nudibranchs , by Region USD Million (2016-2021)
  • Table 14. Marine Drug Bryozoans , by Region USD Million (2016-2021)
  • Table 15. Marine Drug Tunicates , by Region USD Million (2016-2021)
  • Table 16. South America Marine Drug, by Country USD Million (2016-2021)
  • Table 17. South America Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 18. South America Marine Drug, by End Use USD Million (2016-2021)
  • Table 19. South America Marine Drug, by Sources USD Million (2016-2021)
  • Table 20. Brazil Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 21. Brazil Marine Drug, by End Use USD Million (2016-2021)
  • Table 22. Brazil Marine Drug, by Sources USD Million (2016-2021)
  • Table 23. Argentina Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 24. Argentina Marine Drug, by End Use USD Million (2016-2021)
  • Table 25. Argentina Marine Drug, by Sources USD Million (2016-2021)
  • Table 26. Rest of South America Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 27. Rest of South America Marine Drug, by End Use USD Million (2016-2021)
  • Table 28. Rest of South America Marine Drug, by Sources USD Million (2016-2021)
  • Table 29. Asia Pacific Marine Drug, by Country USD Million (2016-2021)
  • Table 30. Asia Pacific Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 31. Asia Pacific Marine Drug, by End Use USD Million (2016-2021)
  • Table 32. Asia Pacific Marine Drug, by Sources USD Million (2016-2021)
  • Table 33. China Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 34. China Marine Drug, by End Use USD Million (2016-2021)
  • Table 35. China Marine Drug, by Sources USD Million (2016-2021)
  • Table 36. Japan Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 37. Japan Marine Drug, by End Use USD Million (2016-2021)
  • Table 38. Japan Marine Drug, by Sources USD Million (2016-2021)
  • Table 39. India Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 40. India Marine Drug, by End Use USD Million (2016-2021)
  • Table 41. India Marine Drug, by Sources USD Million (2016-2021)
  • Table 42. South Korea Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 43. South Korea Marine Drug, by End Use USD Million (2016-2021)
  • Table 44. South Korea Marine Drug, by Sources USD Million (2016-2021)
  • Table 45. Australia Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 46. Australia Marine Drug, by End Use USD Million (2016-2021)
  • Table 47. Australia Marine Drug, by Sources USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Marine Drug, by End Use USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Marine Drug, by Sources USD Million (2016-2021)
  • Table 51. Europe Marine Drug, by Country USD Million (2016-2021)
  • Table 52. Europe Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 53. Europe Marine Drug, by End Use USD Million (2016-2021)
  • Table 54. Europe Marine Drug, by Sources USD Million (2016-2021)
  • Table 55. Germany Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 56. Germany Marine Drug, by End Use USD Million (2016-2021)
  • Table 57. Germany Marine Drug, by Sources USD Million (2016-2021)
  • Table 58. France Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 59. France Marine Drug, by End Use USD Million (2016-2021)
  • Table 60. France Marine Drug, by Sources USD Million (2016-2021)
  • Table 61. Italy Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 62. Italy Marine Drug, by End Use USD Million (2016-2021)
  • Table 63. Italy Marine Drug, by Sources USD Million (2016-2021)
  • Table 64. United Kingdom Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 65. United Kingdom Marine Drug, by End Use USD Million (2016-2021)
  • Table 66. United Kingdom Marine Drug, by Sources USD Million (2016-2021)
  • Table 67. Netherlands Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 68. Netherlands Marine Drug, by End Use USD Million (2016-2021)
  • Table 69. Netherlands Marine Drug, by Sources USD Million (2016-2021)
  • Table 70. Rest of Europe Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 71. Rest of Europe Marine Drug, by End Use USD Million (2016-2021)
  • Table 72. Rest of Europe Marine Drug, by Sources USD Million (2016-2021)
  • Table 73. MEA Marine Drug, by Country USD Million (2016-2021)
  • Table 74. MEA Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 75. MEA Marine Drug, by End Use USD Million (2016-2021)
  • Table 76. MEA Marine Drug, by Sources USD Million (2016-2021)
  • Table 77. Middle East Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 78. Middle East Marine Drug, by End Use USD Million (2016-2021)
  • Table 79. Middle East Marine Drug, by Sources USD Million (2016-2021)
  • Table 80. Africa Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 81. Africa Marine Drug, by End Use USD Million (2016-2021)
  • Table 82. Africa Marine Drug, by Sources USD Million (2016-2021)
  • Table 83. North America Marine Drug, by Country USD Million (2016-2021)
  • Table 84. North America Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 85. North America Marine Drug, by End Use USD Million (2016-2021)
  • Table 86. North America Marine Drug, by Sources USD Million (2016-2021)
  • Table 87. United States Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 88. United States Marine Drug, by End Use USD Million (2016-2021)
  • Table 89. United States Marine Drug, by Sources USD Million (2016-2021)
  • Table 90. Canada Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 91. Canada Marine Drug, by End Use USD Million (2016-2021)
  • Table 92. Canada Marine Drug, by Sources USD Million (2016-2021)
  • Table 93. Mexico Marine Drug, by Distribution Channel USD Million (2016-2021)
  • Table 94. Mexico Marine Drug, by End Use USD Million (2016-2021)
  • Table 95. Mexico Marine Drug, by Sources USD Million (2016-2021)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Marine Drug: by Distribution Channel(USD Million)
  • Table 106. Marine Drug Online {Company Website, E-Commerce Website} , by Region USD Million (2022-2027)
  • Table 107. Marine Drug Offline {Pharma Stores, Local Medical Stores} , by Region USD Million (2022-2027)
  • Table 108. Marine Drug: by End Use(USD Million)
  • Table 109. Marine Drug Hospitals , by Region USD Million (2022-2027)
  • Table 110. Marine Drug Clinics , by Region USD Million (2022-2027)
  • Table 111. Marine Drug Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 112. Marine Drug: by Sources(USD Million)
  • Table 113. Marine Drug Sponges , by Region USD Million (2022-2027)
  • Table 114. Marine Drug Soft Corals , by Region USD Million (2022-2027)
  • Table 115. Marine Drug Sea Fans , by Region USD Million (2022-2027)
  • Table 116. Marine Drug Sea Hares , by Region USD Million (2022-2027)
  • Table 117. Marine Drug Nudibranchs , by Region USD Million (2022-2027)
  • Table 118. Marine Drug Bryozoans , by Region USD Million (2022-2027)
  • Table 119. Marine Drug Tunicates , by Region USD Million (2022-2027)
  • Table 120. South America Marine Drug, by Country USD Million (2022-2027)
  • Table 121. South America Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 122. South America Marine Drug, by End Use USD Million (2022-2027)
  • Table 123. South America Marine Drug, by Sources USD Million (2022-2027)
  • Table 124. Brazil Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 125. Brazil Marine Drug, by End Use USD Million (2022-2027)
  • Table 126. Brazil Marine Drug, by Sources USD Million (2022-2027)
  • Table 127. Argentina Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 128. Argentina Marine Drug, by End Use USD Million (2022-2027)
  • Table 129. Argentina Marine Drug, by Sources USD Million (2022-2027)
  • Table 130. Rest of South America Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 131. Rest of South America Marine Drug, by End Use USD Million (2022-2027)
  • Table 132. Rest of South America Marine Drug, by Sources USD Million (2022-2027)
  • Table 133. Asia Pacific Marine Drug, by Country USD Million (2022-2027)
  • Table 134. Asia Pacific Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 135. Asia Pacific Marine Drug, by End Use USD Million (2022-2027)
  • Table 136. Asia Pacific Marine Drug, by Sources USD Million (2022-2027)
  • Table 137. China Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 138. China Marine Drug, by End Use USD Million (2022-2027)
  • Table 139. China Marine Drug, by Sources USD Million (2022-2027)
  • Table 140. Japan Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 141. Japan Marine Drug, by End Use USD Million (2022-2027)
  • Table 142. Japan Marine Drug, by Sources USD Million (2022-2027)
  • Table 143. India Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 144. India Marine Drug, by End Use USD Million (2022-2027)
  • Table 145. India Marine Drug, by Sources USD Million (2022-2027)
  • Table 146. South Korea Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 147. South Korea Marine Drug, by End Use USD Million (2022-2027)
  • Table 148. South Korea Marine Drug, by Sources USD Million (2022-2027)
  • Table 149. Australia Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 150. Australia Marine Drug, by End Use USD Million (2022-2027)
  • Table 151. Australia Marine Drug, by Sources USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 153. Rest of Asia-Pacific Marine Drug, by End Use USD Million (2022-2027)
  • Table 154. Rest of Asia-Pacific Marine Drug, by Sources USD Million (2022-2027)
  • Table 155. Europe Marine Drug, by Country USD Million (2022-2027)
  • Table 156. Europe Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 157. Europe Marine Drug, by End Use USD Million (2022-2027)
  • Table 158. Europe Marine Drug, by Sources USD Million (2022-2027)
  • Table 159. Germany Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 160. Germany Marine Drug, by End Use USD Million (2022-2027)
  • Table 161. Germany Marine Drug, by Sources USD Million (2022-2027)
  • Table 162. France Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 163. France Marine Drug, by End Use USD Million (2022-2027)
  • Table 164. France Marine Drug, by Sources USD Million (2022-2027)
  • Table 165. Italy Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 166. Italy Marine Drug, by End Use USD Million (2022-2027)
  • Table 167. Italy Marine Drug, by Sources USD Million (2022-2027)
  • Table 168. United Kingdom Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 169. United Kingdom Marine Drug, by End Use USD Million (2022-2027)
  • Table 170. United Kingdom Marine Drug, by Sources USD Million (2022-2027)
  • Table 171. Netherlands Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 172. Netherlands Marine Drug, by End Use USD Million (2022-2027)
  • Table 173. Netherlands Marine Drug, by Sources USD Million (2022-2027)
  • Table 174. Rest of Europe Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 175. Rest of Europe Marine Drug, by End Use USD Million (2022-2027)
  • Table 176. Rest of Europe Marine Drug, by Sources USD Million (2022-2027)
  • Table 177. MEA Marine Drug, by Country USD Million (2022-2027)
  • Table 178. MEA Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 179. MEA Marine Drug, by End Use USD Million (2022-2027)
  • Table 180. MEA Marine Drug, by Sources USD Million (2022-2027)
  • Table 181. Middle East Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 182. Middle East Marine Drug, by End Use USD Million (2022-2027)
  • Table 183. Middle East Marine Drug, by Sources USD Million (2022-2027)
  • Table 184. Africa Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 185. Africa Marine Drug, by End Use USD Million (2022-2027)
  • Table 186. Africa Marine Drug, by Sources USD Million (2022-2027)
  • Table 187. North America Marine Drug, by Country USD Million (2022-2027)
  • Table 188. North America Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 189. North America Marine Drug, by End Use USD Million (2022-2027)
  • Table 190. North America Marine Drug, by Sources USD Million (2022-2027)
  • Table 191. United States Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 192. United States Marine Drug, by End Use USD Million (2022-2027)
  • Table 193. United States Marine Drug, by Sources USD Million (2022-2027)
  • Table 194. Canada Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 195. Canada Marine Drug, by End Use USD Million (2022-2027)
  • Table 196. Canada Marine Drug, by Sources USD Million (2022-2027)
  • Table 197. Mexico Marine Drug, by Distribution Channel USD Million (2022-2027)
  • Table 198. Mexico Marine Drug, by End Use USD Million (2022-2027)
  • Table 199. Mexico Marine Drug, by Sources USD Million (2022-2027)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Marine Drug: by Distribution Channel USD Million (2016-2021)
  • Figure 5. Global Marine Drug: by End Use USD Million (2016-2021)
  • Figure 6. Global Marine Drug: by Sources USD Million (2016-2021)
  • Figure 7. South America Marine Drug Share (%), by Country
  • Figure 8. Asia Pacific Marine Drug Share (%), by Country
  • Figure 9. Europe Marine Drug Share (%), by Country
  • Figure 10. MEA Marine Drug Share (%), by Country
  • Figure 11. North America Marine Drug Share (%), by Country
  • Figure 12. Global Marine Drug share by Players 2021 (%)
  • Figure 13. Global Marine Drug share by Players (Top 3) 2021(%)
  • Figure 14. Global Marine Drug share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. PharmaMar (Spain) Revenue, Net Income and Gross profit
  • Figure 17. PharmaMar (Spain) Revenue: by Geography 2021
  • Figure 18. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer (United States) Revenue: by Geography 2021
  • Figure 20. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. GSK (United Kingdom) Revenue: by Geography 2021
  • Figure 22. Eisai Co., Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Eisai Co., Ltd. (United States) Revenue: by Geography 2021
  • Figure 24. Johnson and Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 25. Johnson and Johnson (United States) Revenue: by Geography 2021
  • Figure 26. Seattle Genetics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Seattle Genetics Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Eisai Co (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Eisai Co (Japan) Revenue: by Geography 2021
  • Figure 30. Tekada (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Tekada (Japan) Revenue: by Geography 2021
  • Figure 32. TerSera Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 33. TerSera Therapeutics (United States) Revenue: by Geography 2021
  • Figure 34. Global Marine Drug: by Distribution Channel USD Million (2022-2027)
  • Figure 35. Global Marine Drug: by End Use USD Million (2022-2027)
  • Figure 36. Global Marine Drug: by Sources USD Million (2022-2027)
  • Figure 37. South America Marine Drug Share (%), by Country
  • Figure 38. Asia Pacific Marine Drug Share (%), by Country
  • Figure 39. Europe Marine Drug Share (%), by Country
  • Figure 40. MEA Marine Drug Share (%), by Country
  • Figure 41. North America Marine Drug Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • PharmaMar (Spain)
  • Pfizer (United States)
  • GSK (United Kingdom)
  • Eisai Co., Ltd. (United States)
  • Johnson and Johnson (United States)
  • Seattle Genetics Inc. (United States)
  • Eisai Co (Japan)
  • Tekada (Japan)
  • TerSera Therapeutics (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation